Close Menu

NEW YORK (GenomeWeb) – NeoGenomics has filed with the US Securities and Exchange Commission for a public offering of approximately $150 million of its common stock, the firm said after the close of the market on Monday.

The company, based in Fort Myers, Florida, said that it plans to use the net proceeds from the offering for general corporate purposes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
25

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.